DE19836684A1
(de)
*
|
1998-08-13 |
2000-02-17 |
Hoechst Schering Agrevo Gmbh |
Herbizide Mittel für tolerante oder resistente Reiskulturen
|
KR100338621B1
(ko)
*
|
2000-01-24 |
2002-05-30 |
전광술 |
제초제 및 그 제조방법
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
KR100607612B1
(ko)
|
2001-06-20 |
2006-08-02 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
ATE327673T1
(de)
|
2001-08-23 |
2006-06-15 |
Bayer Cropscience Sa |
Substituierte propargylamine
|
EP1487877B1
(en)
|
2001-09-18 |
2010-10-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis of tumors
|
KR20070087247A
(ko)
|
2002-01-02 |
2007-08-27 |
제넨테크, 인크. |
종양의 진단 및 치료 방법 및 이를 위한 조성물
|
KR100429139B1
(ko)
*
|
2002-02-28 |
2004-04-29 |
한국화학연구원 |
싸이할로호프와 메타미호프를 유효성분으로 하는 제초제조성물 및 이를 이용하여 화본과 잡초를 방제하는 방법
|
EP1571968A4
(en)
|
2002-04-16 |
2007-10-17 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
ZA200507757B
(en)
|
2003-04-04 |
2007-01-31 |
Genentech Inc |
High concentration antibody and protein formulations
|
US6849579B2
(en)
*
|
2003-06-25 |
2005-02-01 |
Pbi Gordon Corporation |
Synergistic quinclorac herbicidal compositions
|
KR100945327B1
(ko)
|
2003-07-08 |
2010-03-08 |
제넨테크, 인크. |
Il-17a/f 이종 폴리펩티드 및 그의 치료 용도
|
DK2295073T3
(da)
|
2003-11-17 |
2014-07-28 |
Genentech Inc |
Antistof mod cd22 til behandling af tumor af hæmatopoietisk oprindelse
|
JP4570890B2
(ja)
*
|
2004-03-26 |
2010-10-27 |
協友アグリ株式会社 |
除草剤組成物
|
US20060051347A1
(en)
|
2004-09-09 |
2006-03-09 |
Winter Charles M |
Process for concentration of antibodies and therapeutic products thereof
|
CN101141981A
(zh)
|
2005-01-21 |
2008-03-12 |
健泰科生物技术公司 |
Her抗体的固定剂量给药
|
CN101184499B
(zh)
|
2005-02-23 |
2012-03-28 |
阿尔扎公司 |
活性剂向中枢神经系统的鼻内施用
|
ES2440481T3
(es)
|
2005-02-23 |
2014-01-29 |
Genentech, Inc. |
Prolongación del tiempo hasta la progresión de la enfermedad o supervivencia en pacientes de cáncer de ovario usando pertuzumab
|
US20090136505A1
(en)
|
2005-02-23 |
2009-05-28 |
Johanna Bentz |
Intranasal Administration of Active Agents to the Central Nervous System
|
JP5167473B2
(ja)
|
2005-03-03 |
2013-03-21 |
コヴェックス・テクノロジーズ・アイルランド・リミテッド |
抗血管新生化合物
|
CA2610709A1
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
EP1922410A2
(en)
|
2005-08-15 |
2008-05-21 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
CA2630432A1
(en)
|
2005-11-21 |
2007-07-19 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
EP1988768A2
(en)
|
2006-02-17 |
2008-11-12 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
NZ571068A
(en)
|
2006-03-21 |
2012-06-29 |
Genentech Inc |
An antibody that can bind human alpha5beta1
|
EP2614839A3
(en)
|
2006-04-05 |
2015-01-28 |
Genentech, Inc. |
Method for using BOC/CDO to modulate hedgehog signaling
|
AU2007297565A1
(en)
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
JP2009539384A
(ja)
|
2006-06-06 |
2009-11-19 |
ジェネンテック・インコーポレーテッド |
抗dll4抗体および抗dll4抗体使用の方法
|
US8874380B2
(en)
|
2010-12-09 |
2014-10-28 |
Rutgers, The State University Of New Jersey |
Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs
|
WO2008021290A2
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
EP2059533B1
(en)
|
2006-08-30 |
2012-11-14 |
Genentech, Inc. |
Multispecific antibodies
|
EP2368908A3
(en)
|
2006-11-10 |
2011-10-12 |
CovX Technologies Ireland Limited |
Anti- angiogenic compounds
|
CA2676790A1
(en)
|
2007-02-22 |
2008-08-28 |
Genentech, Inc. |
Methods for detecting inflammatory bowel disease
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
SI2171090T1
(sl)
|
2007-06-08 |
2013-07-31 |
Genentech, Inc. |
Markerji genskega izraĹľanja tumorske odpornosti na HER2 inhibitorsko zdravljenje
|
ES2381788T3
(es)
|
2007-07-16 |
2012-05-31 |
Genentech, Inc. |
Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso
|
AU2008276128B2
(en)
|
2007-07-16 |
2013-10-10 |
Genentech, Inc. |
Humanized anti-CD79b antibodies and immunoconjugates and methods of use
|
EP2222875B1
(en)
|
2007-11-07 |
2014-08-20 |
Genentech, Inc. |
Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies
|
DK2220116T3
(da)
|
2007-11-12 |
2012-11-26 |
Theraclone Sciences Inc |
Sammensætninger og fremgangsmåder til terapien og diagnosticeringen af influenza
|
IL287292B
(en)
|
2008-01-31 |
2022-09-01 |
Genentech Inc |
and fusion antibody-drug-cd79b engineered antibodies cysteine-
|
WO2009114560A2
(en)
|
2008-03-10 |
2009-09-17 |
Spaltudaq Corporation |
Compositions and methods for the therapy and diagnosis of cytomegalovirus
|
NZ601815A
(en)
|
2008-03-31 |
2014-10-31 |
Genentech Inc |
Compositions and methods for treating and diagnosing asthma
|
CA2723614C
(en)
|
2008-05-16 |
2015-07-14 |
Genentech, Inc. |
Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
|
MY155603A
(en)
|
2008-07-08 |
2015-11-13 |
Oncomed Pharm Inc |
Notch-binding agents and antagonists and methods of use thereof
|
DK2318832T3
(da)
|
2008-07-15 |
2014-01-20 |
Academia Sinica |
Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder
|
CN101352171B
(zh)
*
|
2008-09-19 |
2012-07-04 |
北京燕化永乐农药有限公司 |
吡嘧磺隆与甲羧除草醚农药的除草剂组合物
|
WO2010056981A2
(en)
|
2008-11-13 |
2010-05-20 |
Massachusetts General Hospital |
Methods and compositions for regulating iron homeostasis by modulation bmp-6
|
US8211434B2
(en)
|
2008-11-26 |
2012-07-03 |
Allergan, Inc. |
KLK-13 antibody inhibitor for treating dry eye
|
HRP20240240T1
(hr)
|
2008-12-09 |
2024-04-26 |
F. Hoffmann - La Roche Ag |
Protutijela anti-pd-l1 i njihova uporaba za poboljšanje funkcije t-stanice
|
SI3260136T1
(sl)
|
2009-03-17 |
2021-05-31 |
Theraclone Sciences, Inc. |
Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
|
CN102356092B
(zh)
|
2009-03-20 |
2014-11-05 |
霍夫曼-拉罗奇有限公司 |
双特异性抗-her抗体
|
AR075998A1
(es)
|
2009-04-01 |
2011-05-11 |
Genentech Inc |
Tratamiento de trastornos resistentes a insulina.composicion farmaceutica. uso. kit
|
CA2757382A1
(en)
|
2009-04-01 |
2010-10-21 |
Kristi Elkins |
Anti-fcrh5 antibodies and immunoconjugates
|
US20100297127A1
(en)
|
2009-04-08 |
2010-11-25 |
Ghilardi Nico P |
Use of il-27 antagonists to treat lupus
|
WO2010121231A1
(en)
|
2009-04-18 |
2010-10-21 |
Genentech, Inc. |
Methods for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies
|
SG175305A1
(en)
|
2009-04-23 |
2011-11-28 |
Theraclone Sciences Inc |
Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
|
CA2762302A1
(en)
|
2009-05-20 |
2010-11-25 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
US20110038871A1
(en)
|
2009-08-11 |
2011-02-17 |
Veena Viswanth |
Ccr2 inhibitors for treating conditions of the eye
|
CN102711826B
(zh)
|
2009-10-22 |
2017-03-29 |
霍夫曼-拉罗奇有限公司 |
用于调控巨噬细胞刺激性蛋白的hepsin活化的方法和组合物
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
BR112012009846B8
(pt)
|
2009-10-26 |
2021-05-25 |
Genentech Inc |
método in vitro e kit para detecção de um anticorpo antifármaco de isotipo ige, e uso de um anticorpo antifármaco de isotipo ige no tratamento de distúrbio mediado por ige
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
WO2011066503A2
(en)
|
2009-11-30 |
2011-06-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
WO2011082187A1
(en)
|
2009-12-30 |
2011-07-07 |
Genentech, Inc. |
Methods for modulating a pdgf-aa mediated biological response
|
KR20130004579A
(ko)
|
2010-02-23 |
2013-01-11 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 조성물 및 방법
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
MX2012012743A
(es)
|
2010-05-03 |
2012-11-23 |
Genentech Inc |
Composiciones y metodos utiles para reducir la viscosidad de formulaciones que contienen proteina.
|
EP2975409B1
(en)
|
2010-05-10 |
2018-10-31 |
Academia Sinica |
Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
|
CN102265853A
(zh)
*
|
2010-06-04 |
2011-12-07 |
南京华洲药业有限公司 |
一种含灭草松和二氯喹啉酸的除草组合物及其应用
|
US20110311527A1
(en)
|
2010-06-16 |
2011-12-22 |
Allergan, Inc. |
IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
|
EP2420250A1
(en)
|
2010-08-13 |
2012-02-22 |
Universitätsklinikum Münster |
Anti-Syndecan-4 antibodies
|
AU2011289275A1
(en)
|
2010-08-12 |
2013-02-21 |
Theraclone Sciences, Inc. |
Anti-hemagglutinin antibody compositions and methods of use thereof
|
JP2013537416A
(ja)
|
2010-08-13 |
2013-10-03 |
メディミューン リミテッド |
変異型Fc領域を含むモノマーポリペプチド及び使用方法
|
WO2012022734A2
(en)
|
2010-08-16 |
2012-02-23 |
Medimmune Limited |
Anti-icam-1 antibodies and methods of use
|
EP3556396B1
(en)
|
2010-08-31 |
2022-04-20 |
Theraclone Sciences, Inc. |
Human immunodeficiency virus (hiv)-neutralizing antibodies
|
WO2012092539A2
(en)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Antibodies to dll4 and uses thereof
|
TW201245223A
(en)
|
2011-02-14 |
2012-11-16 |
Theraclone Sciences Inc |
Compositions and methods for the therapy and diagnosis of influenza
|
JP2014509591A
(ja)
|
2011-03-15 |
2014-04-21 |
セラクローン サイエンシーズ, インコーポレイテッド |
インフルエンザの治療および診断のための組成物および方法
|
RU2016127812A
(ru)
|
2011-03-31 |
2018-12-06 |
Дженентек, Инк. |
Способы введения антагонистов интегрина бета7
|
ES2744226T3
(es)
|
2011-05-08 |
2020-02-24 |
Legochem Biosciences Inc |
Conjugados de proteína-agente activo y método para preparar los mismos
|
IL276182B
(en)
|
2011-05-17 |
2022-09-01 |
Univ Rockefeller |
Neutralizing antibodies against the human immunodeficiency virus and methods of using them
|
EP2718327A1
(en)
|
2011-06-06 |
2014-04-16 |
Neotope Biosciences Limited |
Mcam antagonists and methods of treatment
|
JP2013040160A
(ja)
|
2011-07-01 |
2013-02-28 |
Genentech Inc |
自己免疫疾患を治療するための抗cd83アゴニスト抗体の使用
|
US9120858B2
(en)
|
2011-07-22 |
2015-09-01 |
The Research Foundation Of State University Of New York |
Antibodies to the B12-transcobalamin receptor
|
WO2013015821A1
(en)
|
2011-07-22 |
2013-01-31 |
The Research Foundation Of State University Of New York |
Antibodies to the b12-transcobalamin receptor
|
US9890207B2
(en)
|
2011-07-25 |
2018-02-13 |
California Institute Of Technology |
Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120
|
US9493549B2
(en)
|
2011-07-25 |
2016-11-15 |
The Rockefeller University |
Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
|
US8822651B2
(en)
|
2011-08-30 |
2014-09-02 |
Theraclone Sciences, Inc. |
Human rhinovirus (HRV) antibodies
|
JP2015509091A
(ja)
|
2012-01-09 |
2015-03-26 |
ザ スクリプス リサーチ インスティテュート |
ヒト化抗体
|
EP2802603A4
(en)
|
2012-01-09 |
2015-11-04 |
Scripps Research Inst |
REGIONS DETERMINING ULTRALONGUAL COMPLEMENTARYITY AND USES THEREOF
|
US20130243750A1
(en)
|
2012-01-31 |
2013-09-19 |
Genentech, Inc. |
Anti-ige antibodies and methods using same
|
AU2013240261A1
(en)
|
2012-03-27 |
2014-09-18 |
Genentech, Inc. |
Diagnosis and treatments relating to HER3 inhibitors
|
BR112014023348A2
(pt)
|
2012-03-27 |
2019-03-19 |
Genentech, Inc. |
Métodos de prognóstico, de diagnóstico e tratamento
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
WO2013192589A1
(en)
|
2012-06-21 |
2013-12-27 |
California Institute Of Technology |
Antibodies targeting hiv escape mutants
|
WO2014018375A1
(en)
|
2012-07-23 |
2014-01-30 |
Xenon Pharmaceuticals Inc. |
Cyp8b1 and uses thereof in therapeutic and diagnostic methods
|
EP2885311B1
(en)
|
2012-08-18 |
2020-01-01 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
EP2888238A4
(en)
|
2012-08-21 |
2016-01-27 |
Academia Sinica |
BENZOCYCLO-OCTYNE COMPOUNDS AND USES THEREOF
|
TWI595007B
(zh)
|
2012-09-10 |
2017-08-11 |
Neotope Biosciences Ltd |
抗mcam抗體及相關使用方法
|
ES2738305T3
(es)
|
2012-10-05 |
2020-01-21 |
Hoffmann La Roche |
Procedimientos para diagnosticar y tratar enfermedades inflamatorias intestinales
|
SI2908912T1
(sl)
|
2012-10-18 |
2021-03-31 |
The Rockefeller University |
Široko nevtralizirajoča protitelesa proti HIV
|
EP2911692B1
(en)
|
2012-10-26 |
2019-08-21 |
The University of Queensland |
Use of endocytosis inhibitors and antibodies for cancer therapy
|
KR102175688B1
(ko)
|
2013-03-27 |
2020-11-06 |
제넨테크, 인크. |
베타7 인테그린 길항제를 사용하는 위장 염증성 장애의 치료를 평가하기 위한 바이오마커의 사용
|
US20160053023A1
(en)
|
2013-04-09 |
2016-02-25 |
Annexon, Inc. |
Methods of treatment for neuromyelitis optica
|
US10086054B2
(en)
|
2013-06-26 |
2018-10-02 |
Academia Sinica |
RM2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
CA2916521C
(en)
|
2013-07-09 |
2023-03-07 |
Annexon, Inc. |
Anti-complement factor c1q antibodies and uses thereof
|
EP3022224A2
(en)
|
2013-07-18 |
2016-05-25 |
Fabrus, Inc. |
Antibodies with ultralong complementarity determining regions
|
JP6687520B2
(ja)
|
2013-07-18 |
2020-04-22 |
トーラス バイオサイエンシズ リミテッド ライアビリティ カンパニー |
極めて長い相補性決定領域を有するヒト化抗体
|
EP3041484B1
(en)
|
2013-09-06 |
2021-03-03 |
Academia Sinica |
Human inkt cell activation using glycolipids with altered glycosyl groups
|
WO2015050959A1
(en)
|
2013-10-01 |
2015-04-09 |
Yale University |
Anti-kit antibodies and methods of use thereof
|
CN105849124B
(zh)
|
2013-12-20 |
2022-04-12 |
豪夫迈·罗氏有限公司 |
双重特异性抗体
|
SG11201605745VA
(en)
|
2014-01-14 |
2016-08-30 |
Wisconsin Med College Inc |
Targeting clptm1l for treatment and prevention of cancer
|
US10023892B2
(en)
|
2014-05-27 |
2018-07-17 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
KR20160104727A
(ko)
|
2014-01-16 |
2016-09-05 |
아카데미아 시니카 |
암의 치료 및 검출을 위한 조성물 및 방법
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
JP6562942B2
(ja)
|
2014-03-27 |
2019-08-28 |
アカデミア シニカAcademia Sinica |
反応性標識化合物およびその使用
|
KR20220065091A
(ko)
|
2014-03-27 |
2022-05-19 |
제넨테크, 인크. |
염증성 장 질환의 진단 및 치료 방법
|
CN104012549B
(zh)
*
|
2014-05-07 |
2016-08-17 |
广东中迅农科股份有限公司 |
一种含有双唑草腈和双草醚的除草组合物
|
CN104012547A
(zh)
*
|
2014-05-07 |
2014-09-03 |
广东中迅农科股份有限公司 |
一种含有双唑草腈和氰氟草酯的除草组合物
|
EP3142700B1
(en)
|
2014-05-16 |
2021-03-03 |
Medimmune, LLC |
Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties
|
KR20170003720A
(ko)
|
2014-05-27 |
2017-01-09 |
아카데미아 시니카 |
항-cd20 글리코항체 및 이의 용도
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
KR102512592B1
(ko)
|
2014-05-27 |
2023-03-21 |
아카데미아 시니카 |
항-her2 글리코항체 및 이의 용도
|
US11332523B2
(en)
|
2014-05-28 |
2022-05-17 |
Academia Sinica |
Anti-TNF-alpha glycoantibodies and uses thereof
|
EP3613433B1
(en)
|
2014-05-30 |
2022-01-05 |
Shanghai Henlius Biotech, Inc. |
Anti-epidermal growth factor receptor (egfr) antibodies
|
CN107106679B
(zh)
|
2014-08-08 |
2022-07-26 |
艾利妥 |
抗trem2抗体及其使用方法
|
US9879042B2
(en)
|
2014-09-08 |
2018-01-30 |
Academia Sinica |
Human iNKT cell activation using glycolipids
|
CN104255750A
(zh)
*
|
2014-09-10 |
2015-01-07 |
广东中迅农科股份有限公司 |
含有双唑草腈和丙草胺的除草组合物
|
WO2016073157A1
(en)
|
2014-11-06 |
2016-05-12 |
Genentech, Inc. |
Anti-ang2 antibodies and methods of use thereof
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
JP6789954B2
(ja)
|
2015-01-22 |
2020-11-25 |
ビーエーエスエフ アグロ ベー.ブイ. |
サフルフェナシルを含む3成分除草剤の組合せ
|
AU2015378564A1
(en)
|
2015-01-24 |
2017-07-13 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
JP2018506275A
(ja)
|
2015-01-28 |
2018-03-08 |
ジェネンテック, インコーポレイテッド |
多発性硬化症の遺伝子発現マーカー及び治療
|
WO2016138207A1
(en)
|
2015-02-26 |
2016-09-01 |
Genentech, Inc. |
Integrin beta7 antagonists and methods of treating crohn's disease
|
CN107106671B
(zh)
|
2015-04-03 |
2022-01-14 |
优瑞科生物技术公司 |
靶向afp肽/mhc复合体的构建体及其用途
|
CA2981851A1
(en)
|
2015-04-07 |
2016-10-13 |
Alector Llc |
Anti-sortilin antibodies and methods of use thereof
|
CN104757013A
(zh)
*
|
2015-04-18 |
2015-07-08 |
广东中迅农科股份有限公司 |
含有双唑草腈和四唑酰草胺及精噁唑禾草灵的除草组合物
|
EP3302710A4
(en)
|
2015-06-03 |
2019-02-20 |
The University of Queensland |
MOBILIZERS AND USE THEREOF
|
WO2016201389A2
(en)
|
2015-06-12 |
2016-12-15 |
Alector Llc |
Anti-cd33 antibodies and methods of use thereof
|
WO2016201388A2
(en)
|
2015-06-12 |
2016-12-15 |
Alector Llc |
Anti-cd33 antibodies and methods of use thereof
|
US11219215B2
(en)
|
2015-07-10 |
2022-01-11 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and specific inhibitors of protoporphyrinogen oxidase
|
EP3319427B1
(en)
|
2015-07-10 |
2019-04-17 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and dimethenamid
|
WO2017009137A1
(en)
|
2015-07-10 |
2017-01-19 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylinandpethoxamid
|
EP3319436B1
(en)
*
|
2015-07-10 |
2019-09-11 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and quinmerac
|
AU2016292524B2
(en)
|
2015-07-10 |
2020-05-28 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and saflufenacil
|
JP6875368B2
(ja)
|
2015-07-10 |
2021-05-26 |
ビーエーエスエフ アグロ ベー.ブイ. |
シンメチリン及びアセトクロール又はプレチラクロールを含む除草剤組成物
|
US11219212B2
(en)
|
2015-07-10 |
2022-01-11 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and imazamox
|
EA201890260A1
(ru)
|
2015-07-10 |
2018-07-31 |
Басф Агро Б.В. |
Гербицидная композиция, содержащая цинметилин и пироксасульфон
|
US20180184659A1
(en)
|
2015-07-10 |
2018-07-05 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and specific pigment synthesis inhibitors
|
CN105076162B
(zh)
*
|
2015-08-05 |
2018-03-09 |
安徽华星化工有限公司 |
一种含有乙氧氟草醚和双唑草腈的水稻田除草组合物
|
JP2018525999A
(ja)
|
2015-08-28 |
2018-09-13 |
アレクトル エルエルシー |
抗Siglec−7抗体及びその使用方法
|
US20190330335A1
(en)
|
2015-10-06 |
2019-10-31 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
RU2022103665A
(ru)
|
2015-10-23 |
2022-03-05 |
Еурека Терапьютикс, Инк. |
Химерные конструкции антитело/t-клеточный рецептор и их применения
|
CN116003596A
(zh)
|
2015-10-29 |
2023-04-25 |
艾利妥 |
抗siglec-9抗体及其使用方法
|
CN107847606A
(zh)
|
2015-11-25 |
2018-03-27 |
乐高化学生物科学股份有限公司 |
包含自降解基团的缀合物及其相关方法
|
BR112018010945A2
(pt)
|
2015-12-30 |
2018-12-04 |
Genentech Inc |
formulações com degradação de polissorbato reduzida
|
US11472877B2
(en)
|
2016-03-04 |
2022-10-18 |
Alector Llc |
Anti-TREM1 antibodies and methods of use thereof
|
EP3426693A4
(en)
|
2016-03-08 |
2019-11-13 |
Academia Sinica |
PROCESS FOR MODULAR SYNTHESIS OF N-GLYCANES AND ARRANGEMENTS THEREOF
|
CN105901005A
(zh)
*
|
2016-05-16 |
2016-08-31 |
河北博嘉农业有限公司 |
一种含有双唑草腈的除草组合物
|
CN105918339A
(zh)
*
|
2016-05-19 |
2016-09-07 |
河北博嘉农业有限公司 |
一种含有双唑草腈和磺酰脲类除草剂的除草组合物
|
WO2018014260A1
(en)
|
2016-07-20 |
2018-01-25 |
Nanjing Legend Biotech Co., Ltd. |
Multispecific antigen binding proteins and methods of use thereof
|
TWI764917B
(zh)
|
2016-08-22 |
2022-05-21 |
醣基生醫股份有限公司 |
抗體、結合片段及使用方法
|
KR102391338B1
(ko)
|
2016-09-16 |
2022-04-26 |
상하이 헨리우스 바이오테크, 인크. |
항-pd-1 항체
|
WO2018068201A1
(en)
|
2016-10-11 |
2018-04-19 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against ctla-4
|
CN108064865A
(zh)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
一种除草组合物
|
CN108064860A
(zh)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
一种除草组合物
|
CN108064866A
(zh)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
一种除草组合物
|
CN108064868A
(zh)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
一种除草组合物
|
CN108064871A
(zh)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
一种除草组合物
|
CN106561695A
(zh)
*
|
2016-11-15 |
2017-04-19 |
江苏龙灯化学有限公司 |
一种除草组合物
|
KR102085798B1
(ko)
|
2016-12-28 |
2020-03-06 |
주식회사 인투셀 |
베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
|
EP3568468A4
(en)
|
2017-01-12 |
2020-12-30 |
Eureka Therapeutics, Inc. |
RECOMBINATION PRODUCTS TARGETING PEPTIDE HISTONE H3 / MHC COMPLEXES AND THEIR USES
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
CN107047592A
(zh)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
一种含双唑草腈与苄嘧磺隆的除草组合物及其应用
|
CN106889094A
(zh)
*
|
2017-02-27 |
2017-06-27 |
南京华洲药业有限公司 |
一种含双唑草腈与吡嘧磺隆的除草组合物及其应用
|
CN107047578A
(zh)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
一种含双唑草腈与丙炔噁草酮的除草组合物及其应用
|
CN106889082A
(zh)
*
|
2017-02-27 |
2017-06-27 |
南京华洲药业有限公司 |
一种含双唑草腈与噁草酮的除草组合物及其应用
|
CN106889084A
(zh)
*
|
2017-02-27 |
2017-06-27 |
南京华洲药业有限公司 |
一种含双唑草腈与灭草松的除草组合物及其应用
|
CN106857575A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与丁草胺的除草组合物及其应用
|
CN106857621A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与禾草敌的除草组合物及其应用
|
CN106857577A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与氟硫草定的除草组合物及其应用
|
CN106857609A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与乙氧嘧磺隆的除草组合物及其应用
|
CN106857576A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与苯噻酰草胺的除草组合物及其应用
|
CN106857579A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与三嗪氟草胺的除草组合物及其应用
|
CN107047594A
(zh)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
一种含双唑草腈与氯吡嘧磺隆的除草组合物及其应用
|
CN106889083B
(zh)
*
|
2017-02-27 |
2019-02-12 |
南京华洲药业有限公司 |
一种含双唑草腈与异恶草酮的除草组合物及其应用
|
CN107047582A
(zh)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
一种含双唑草腈与禾草畏的除草组合物及其应用
|
CN106857578A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与乙草胺的除草组合物及其应用
|
CN107047593A
(zh)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
一种含双唑草腈与乙氧磺隆的除草组合物及其应用
|
CN106857580A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与吡氟酰草胺的除草组合物及其应用
|
CN106857600A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与异丙隆的除草组合物及其应用
|
RU2665790C1
(ru)
|
2017-04-17 |
2018-09-04 |
Закрытое Акционерное Общество "Биокад" |
Моноклональное антитело к pd-l1
|
EP4230649A3
(en)
|
2017-04-25 |
2023-10-25 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
|
EP3615574A4
(en)
|
2017-04-26 |
2021-02-24 |
Eureka Therapeutics, Inc. |
CONSTRUCTIONS SPECIFICALLY RECOGNIZING GLYPICANE 3 AND USES OF SUCH LATEST
|
CA3059755A1
(en)
|
2017-04-26 |
2018-11-01 |
Eureka Therapeutics, Inc. |
Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof
|
US11359014B2
(en)
|
2017-05-16 |
2022-06-14 |
Alector Llc |
Anti-siglec-5 antibodies and methods of use thereof
|
CN107114382A
(zh)
*
|
2017-05-22 |
2017-09-01 |
娄天成 |
一种含双唑草腈和敌稗的农药组合物及其应用
|
CN107094781A
(zh)
*
|
2017-05-22 |
2017-08-29 |
孙金金 |
一种含双唑草腈和二氯喹啉酸的农药组合物及其应用
|
CN106954634A
(zh)
*
|
2017-05-22 |
2017-07-18 |
娄天成 |
一种含双唑草腈和莎稗磷的农药组合物及其应用
|
CN110753703B
(zh)
|
2017-05-23 |
2024-04-09 |
德国亥姆霍兹慕尼黑中心健康与环境研究中心(有限公司) |
新的cd73抗体、其制备和用途
|
CN107006498A
(zh)
*
|
2017-05-24 |
2017-08-04 |
江苏省农用激素工程技术研究中心有限公司 |
用于防除稻田杂草的除草组合物
|
RU2653545C1
(ru)
*
|
2017-07-17 |
2018-05-11 |
АО "Щелково Агрохим" |
Гербицидная композиция на основе бентазона для защиты зернобобовых культур
|
CN111094334A
(zh)
|
2017-07-19 |
2020-05-01 |
美国卫生与公众服务部 |
用于诊断和治疗乙肝病毒感染的抗体和方法
|
RS64419B1
(sr)
|
2017-08-03 |
2023-09-29 |
Alector Llc |
Anti-trem2 antitela i postupci za njihovu upotrebu
|
CA3057447A1
(en)
|
2017-08-03 |
2019-02-07 |
Alector Llc |
Anti-cd33 antibodies and methods of use thereof
|
RU2698048C2
(ru)
|
2017-10-03 |
2019-08-21 |
Закрытое Акционерное Общество "Биокад" |
МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
|
EA039662B1
(ru)
|
2017-10-03 |
2022-02-24 |
Закрытое Акционерное Общество "Биокад" |
Антитела, специфичные к cd47 и pd-l1
|
AU2018388791A1
(en)
|
2017-12-19 |
2020-07-16 |
The Rockefeller University |
Human IgG Fc domain variants with improved effector function
|
CA3082280A1
(en)
|
2017-12-28 |
2019-07-04 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against tigit
|
JP7366908B2
(ja)
|
2018-01-15 |
2023-10-23 |
ナンジン レジェンド バイオテック カンパニー,リミテッド |
Pd-1に対する単一ドメイン抗体及びその変異体
|
US20210251899A1
(en)
|
2018-01-25 |
2021-08-19 |
Acm Biolabs Pte Ltd |
Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof
|
CN108371183A
(zh)
*
|
2018-02-02 |
2018-08-07 |
河北中天邦正生物科技股份公司 |
一种农药组合物及其应用
|
CN108308187A
(zh)
*
|
2018-02-11 |
2018-07-24 |
河北中天邦正生物科技股份公司 |
一种农药组合物及其应用
|
SG11202006674QA
(en)
|
2018-03-30 |
2020-08-28 |
Nanjing Legend Biotech Co Ltd |
Single-domain antibodies against lag-3 and uses thereof
|
WO2019213416A1
(en)
|
2018-05-02 |
2019-11-07 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection
|
EP3806904A4
(en)
|
2018-06-18 |
2022-04-27 |
Eureka Therapeutics, Inc. |
PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED CONSTRUCTS AND USES THEREOF
|
CN112334479A
(zh)
|
2018-07-13 |
2021-02-05 |
南京传奇生物科技有限公司 |
用于治疗感染性疾病的共受体系统
|
PE20210186A1
(es)
|
2018-07-13 |
2021-02-02 |
Alector Llc |
Anticuerpos anti-sortilina y metodos para su uso
|
JP2021531027A
(ja)
|
2018-07-27 |
2021-11-18 |
アレクトル エルエルシー |
抗Siglec−5抗体及びその使用方法
|
WO2020053325A1
(en)
|
2018-09-12 |
2020-03-19 |
Acm Biolabs Pte Ltd |
Polymersomes comprising a covalently bound antigen as well as methods of making and uses thereof
|
RU2724469C2
(ru)
|
2018-10-31 |
2020-06-23 |
Закрытое Акционерное Общество "Биокад" |
Моноклональное антитело, которое специфически связывается с cd20
|
EA202191058A1
(ru)
|
2018-11-16 |
2021-10-07 |
Мемориал Слоун Кеттеринг Кэнсер Сентр |
Антитела против муцина-16 и способы их применения
|
RU2734432C1
(ru)
|
2019-04-23 |
2020-10-16 |
Закрытое Акционерное Общество "Биокад" |
Моноклональное антитело, которое специфически связывается с GITR
|
US20220226496A1
(en)
|
2019-05-02 |
2022-07-21 |
Legochem Biosciences, Inc. |
Ligand-drug conjugate including linker having tris structure
|
AR119293A1
(es)
|
2019-06-28 |
2021-12-09 |
Genentech Inc |
Composición y métodos para estabilizar formulaciones líquidas de proteínas
|
CN110178842A
(zh)
*
|
2019-07-05 |
2019-08-30 |
南京农业大学 |
一种丙草胺与双唑草腈治理抗性稗组合物及其应用
|
BR112022000876A2
(pt)
|
2019-07-19 |
2022-04-26 |
Oncoresponse Inc |
Anticorpos imunomoduladores e métodos de uso destes
|
CN112300279A
(zh)
|
2019-07-26 |
2021-02-02 |
上海复宏汉霖生物技术股份有限公司 |
针对抗cd73抗体和变体的方法和组合物
|
CN113993900B
(zh)
|
2020-05-27 |
2023-08-04 |
舒泰神(北京)生物制药股份有限公司 |
特异性识别神经生长因子的抗体及其用途
|
BR112023014418A2
(pt)
|
2021-01-20 |
2023-10-31 |
Oncoresponse Inc |
Anticorpos imunomoduladores e usos dos mesmos
|
AU2022258552A1
(en)
|
2021-04-12 |
2023-10-19 |
Acm Biolabs Pte Ltd |
Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof
|
TW202317633A
(zh)
|
2021-07-08 |
2023-05-01 |
美商舒泰神(加州)生物科技有限公司 |
特異性識別tnfr2的抗體及其用途
|
WO2023284714A1
(zh)
|
2021-07-14 |
2023-01-19 |
舒泰神(北京)生物制药股份有限公司 |
特异性识别cd40的抗体及其应用
|
WO2024020407A1
(en)
|
2022-07-19 |
2024-01-25 |
Staidson Biopharma Inc. |
Antibodies specifically recognizing b- and t-lymphocyte attenuator (btla) and uses thereof
|